Bright Grey and Scottish Provident have sought to clarify breast cancer cover from critical illness (CI) providers following recent changes made to their definitions.
Scottish Provident also announced it has paid more than £1bn to claimants since 2003. The providers added additional cover for low grade prostate cancer and an early form of breast cancer known as ductal carinoma in situ (DCIS), both of which will receive a payment of up to 20% of the sum assured. The move sparked a debate in the industry about the covering of less severe conditions and the definitions surrounding them. Roger Edwards, proposition director for Bright Grey and Scot Prov, explained the differences of cover available and changes made by the providers. "One aspect hi...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes